We report the clinical and histologic features of 2 cutaneous tumors demonstrating many of the usual features of sclerotic fibroma, an entity that is well described in the literature. Our cases differed from the usual form of sclerotic fibroma in that they demonstrated marked focal cellular pleomorphism without increased mitotic activity. We suggest the term pleomorphic sclerotic fibroma for these lesions.

Barax GN, Lebwohl M, Phelps RG: Multiple hamartoma syndrome. J Am Acad Dermatol 1987;17:342–346.
Brownstein MH, Mehregan AH, Bikowski JB, Lupulescu A, Patterson JC: The dermatopathology of Cowden’s syndrome. Br J Dermatol 1979;100:667–673.
Lloyd KM, Dennis M: Cowden’s disease: A possible new symptom complex with multiple system involvement. Ann Intern Med 1963; 58:136–142.
Starink TM: Cowdens’s disease: Analysis of fourteen new cases. J Am Acad Dermatol 1984;11:1127–1141.
Weary PE, Gorlin RJ, Gentry WC, Comer JE, Greer KE: Multiple hamartoma syndrome. Arch Dermatol 1972;106:682–690.
Lo WL, Wong CK: Solitary sclerotic fibroma. J Cutan Pathol 1990;17:269–273.
Rapini RP, Golitz LE: Hypocellular fibromas (abstract). J Cutan Pathol 1986;13:460.
Rapini RP, Golitz LE: Sclerotic fibroma of the skin. J Am Acad Dermatol 1989;20:266–271.
Metcalf JS, Maize JC, LeBoit PE: circumscribed storiform collagenoma (sclerosing fibroma). Am J Dermatopathol 1991;13:122– 129.
Choi US, Hwang SY, Chun SI: Sclerotic fibroma of the skin. J Am Acad Dermatol 1991; 24:508–509.
Nogita T, Akiyoshi E, Kawashima M: Sclerotic fibromas of the skin. J Dermatol 1991;18:472– 474.
Shitabata PK, Crouch EC, Fitzgibbon JF, Swanson PE, Adesokan PN, Wick MR: Cutaneous sclerotic fibroma: Immunohistochemical evidence of a fibroblastic neoplasm with ongoing type I collagen synthesis. Am J Dermatopathol 1995;17:339–343.
Donati P, Amantea A, Carducci M, Balus L: Sclerotic (hypocellular) fibromas of the skin. Br J Dermatol 1991;124:395–396.
Pujol RM, de Castro F, Schroeter AL, Su WPD: Solitary sclerotic fibroma of the skin: A sclerotic dermatofibroma? Am J Dermatopathol 1996;18:620–624.
McCalmont TH: Sclerotic fibroma: A fossil no longer. J Cutan Pathol 1994;21:82–85.
Kuhn C 3rd, Boldt J, King TE Jr, Crouch E, Vartio T, McDonald JA: An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am Rev Respir Dis 1989;140:1693–1703.
McDonald JA, Broekelmann TJ, Matheke ML, Crouch E, Koo M, Kuhn C 3rd: A monoclonal antibody to the carboxyterminal domain of procollagen type I visualizes collagen synthesizing fibroblasts. J Clin Invest 1986;78:1237– 1244.
Satoh T, Katsumata M, Asaka Y, Tokura Y, Takigawa M: Solitary sclerotic fibroma of the skin. Int J Dermatol 1991;30:505–506.
Furue M, Harada S: Sclerotic fibroma of the skin arising on the nasal ala. J Dermatol 1993; 20:252–253.
Kamino H, Reddy VB: Unusual benign fibrous and fibrohistiocytic tumors of the skin. Dermatol Clin 1992;10:203–217.
Reid M, Gray C, Fea J, Bird C: Immunohistological demonstration of factors XIIIa and XIIIs in reactive neoplastic fibroblastic and fibrohistiocytic lesions. Histopathology 1986;10:1171– 1178.
Zelger BW, Zelger BG, Rappersberger K: Prominent myofibroblastic differentiation: A pitfall in the diagnostic of dermatofibroma. Am J Dermatopathol 1997;19:138–146.
Kamino H, Lee JY, Berke A: Pleomorphic fibroma of the skin: A benign neoplasm with cytologic atypia: A clinicopathologic study of eight cases. Am J Surg Pathol 1989;13:107– 113.
Shmookler BM, Enzinger FM: Pleomorphic lipoma: A benign tumor simulating liposarcoma. A clinico-pathologic analysis of 48 cases. Cancer 1981;47:126–133.
Enzinger FM, Weiss SW: Soft Tissue Tumors. St Louis, Mosby, 1988, pp 386–391.
Martínez JA, Quecedo E, Fortea JM, Oliver V, Aliaga A: Pleomorphic angioleiomyoma. Am J Dermatopathol 1996;18:409–412.
Dahl I: Ancient neurilemmoma (schwannoma). Acta Pathol Microbiol (A) 1977;85: 812–818.
Tamada S, Ackerman AB: Dermatofibroma with monster cells. Am J Dermatopathol 1987; 95:380–387.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.